News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
357,226 Results
Type
Article (23863)
Company Profile (18)
Press Release (333345)
Section
Business (121089)
Career Advice (1417)
Deals (17657)
Drug Delivery (51)
Drug Development (43268)
Employer Resources (96)
FDA (8733)
Job Trends (8620)
News (193160)
Policy (17457)
Tag
Academia (1468)
Africa (555)
Alabama (20)
Allergies (18)
Alliances (33241)
Alzheimer's disease (642)
Antibody-drug conjugate (ADC) (33)
Approvals (8706)
Arizona (54)
Artificial intelligence (38)
Asia (20841)
Australia (3490)
Bankruptcy (155)
Best Places to Work (6822)
Biosimilars (17)
C2C Services and Suppliers (36264)
California (420)
Canada (363)
Cancer (103)
Career advice (1202)
CAR-T (19)
Cell therapy (41)
China (29)
Clinical research (33319)
Collaboration (34)
Colorado (23)
COVID-19 (1426)
Cystic fibrosis (37)
Data (18)
Diabetes (19)
Diagnostics (3166)
Diversity, equity & inclusion (29)
Drug pricing (30)
Earnings (52431)
Employer resources (81)
Europe (49287)
Events (52222)
FDA (8758)
Florida (70)
Funding (21)
Gene therapy (31)
GLP-1 (271)
Government (2294)
Healthcare (10214)
Hotbed/Location (247133)
Idaho (19)
Illinois (100)
Indiana (57)
Infectious disease (1434)
Inflammatory bowel disease (58)
Interviews (264)
IPO (8259)
Job creations (1821)
Job search strategy (1018)
Kansas (46)
Layoffs (206)
Legal (4438)
Liver cancer (25)
Lung cancer (23)
Maine (20)
Management (29)
Manufacturing (32)
Maryland (106)
Massachusetts (232)
Medical device (6479)
Medtech (6481)
Mergers & acquisitions (9285)
Metabolic disorders (87)
Neuroscience (676)
New Jersey (39)
New York (45)
NextGen Class of 2024 (3453)
Non-profit (2681)
North Carolina (78)
Obesity (50)
Opinion (136)
Patents (21)
Pennsylvania (29)
People (27882)
Phase I (9913)
Phase II (14245)
Phase III (11954)
Podcasts (41)
Policy (27)
Postmarket research (1684)
Preclinical (4327)
Rare diseases (45)
Real estate (2611)
Recruiting (36)
Regulatory (11115)
Research institute (1346)
Resumes & cover letters (217)
South America (761)
Sponsored (17)
Startups (1583)
Texas (47)
United States (1540)
Vaccines (268)
Washington State (77)
Weight loss (51)
Date
Today (33)
Last 7 days (279)
Last 30 days (1044)
Last 365 days (21831)
2024 (12354)
2023 (22753)
2022 (29305)
2021 (31036)
2020 (30172)
2019 (25779)
2018 (19049)
2017 (18060)
2016 (17472)
2015 (19907)
2014 (16595)
2013 (14521)
2012 (14385)
2011 (13849)
2010 (13074)
357,226 Results for "merck sharp and dohme".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility
Sharps Technology, Inc. received a signed $30 million purchase order from Nephron Pharmaceuticals, representing their first 12 months of syringe purchase commitments.
June 13, 2024
·
6 min read
Infectious Disease
CDC Backs Merck’s Capvaxive, Tees Up Pneumococcal Competition With Pfizer
In a potential challenge to Pfizer’s Prevnar 20, Merck’s Capvaxive has been recommended by the Centers for Disease Control and Protection for use in preventing invasive pneumococcal disease in adults.
July 1, 2024
·
2 min read
·
Tristan Manalac
Policy
CDC Backs Merck’s Capvaxive, Tees Up Pneumococcal Competition With Pfizer
In a potential challenge to Pfizer’s Prevnar 20, Merck’s Capvaxive has been recommended by the Centers for Disease Control and Protection for use in preventing invasive pneumococcal disease in adults.
July 1, 2024
·
2 min read
·
Tristan Manalac
Pharm Country
Sharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in Colombia
Sharps Technology, Inc., an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, has made the first shipment of its 1mL and 3mL Securegard smart safety syringe line to the Latin American healthcare market.
June 17, 2024
·
4 min read
BioMidwest
PharmaLink Announces Execution of Returns Processing Service Agreement With Merck
PharmaLink, Inc., an Industry-leading pharmaceutical reverse distributor, announced a new contract relationship with biopharmaceutical manufacturer Merck Sharp & Dohme LLC.
June 13, 2023
·
2 min read
RSV
Merck Challenges AstraZeneca, Sanofi With Phase IIb/III Data for RSV Antibody
Merck’s clesrovimab lowered the risk of medically attended lower respiratory infections associated with RSV infection when used in infants, according to topline results announced Tuesday.
July 23, 2024
·
2 min read
·
Tristan Manalac
Policy
Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes
Sharps Technology, Inc., an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, issues a shareholder update from Robert Hayes, the Company’s Chief Executive Officer.
May 28, 2024
·
6 min read
Pharm Country
Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
Sharps Technology, Inc., an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products issues a shareholder update from Robert Hayes, the Company’s Chief Executive Officer.
May 31, 2024
·
7 min read
Deals
Merck to Acquire EyeBio
Merck, known as MSD outside of the United States and Canada, and Eyebiotech Limited, a privately held ophthalmology-focused biotechnology company, announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio.
May 29, 2024
·
9 min read
Policy
FDA Action Alert: Merck, BMS, Sarepta and More
The FDA has a packed calendar this week, with six decisions on the docket, including ones for Merck’s Keytruda, BMS’s Krazati and Sarepta’s Elevidys.
June 12, 2024
·
4 min read
·
Tristan Manalac
1 of 35,723
Next